Search For "clinical trial"
Hetero announces interim clinical results from Phase III clinical trials o
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 9 (ANI): Hetero, a globally renowned vertically integrated pharmaceutical organization, on Friday announced the interim clinical results from Phase III clinical trials of Molnupiravir in mild Covid-19 patients conducted across multiple COVID-19 dedicated h
Read More
Bharat Biotech releases Phase 3 trial results of Covaxin, claims vaccine e
Updated : 4 years, 8 months ago IST
Hyderabad (Telangana) [India], July 3 (ANI): Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent effective against COVID-19.
Read More
'Submit results on Covavax adult trials first': Govt panel to SII on Covid
Updated : 4 years, 8 months ago IST
New Delhi [India], July 1 (ANI): An expert panel constituted by the government has recommended against granting permission to the Serum Institute of India (SII) to conduct phase two and three clinical trials of Covavax COVID-19 vaccine on children aged between 2-17 years, said sources on
Read More
Johnson & Johnson won't be conducting COVID-19 vaccine trials in India
Updated : 4 years, 8 months ago IST
New Delhi [India], June 29 (ANI): Johnson & Johnson will not be conducting local trials in India for its single-dose COVID-19 vaccine, a spokesperson of the US-based pharma company said on Tuesday.
Read More
Bharat Biotech has submitted Covaxin's Phase III trial data to DCGI: Govt
Updated : 4 years, 8 months ago IST
New Delhi [India], June 21 (ANI): The Hyderabad-based COVID vaccine manufacturing company Bharat Biotech submitted data from the Phase III clinical trials of Covaxin to Drugs Controller General of India (DCGI) over the weekend, according to government sources.
Read More
Study finds common antibiotic useful in accelerating recovery in tuberculo
Updated : 4 years, 8 months ago IST
Singapore, June 20 (ANI): A clinical trial in 30 patients led by Yong Loo Lin School of Medicine researchers shows that doxycycline, in combination with tuberculosis treatment, reduced lung cavity size and increased other markers of recovery.
Read More
AstraZeneca's antibody treatment fails to protect against COVID-19
Updated : 4 years, 9 months ago IST
Moscow [Russia], June 15 (ANI/Sputnik): AstraZeneca announced on Tuesday that the clinical trial of its long-acting antibody cocktail has not provided evidence of effectiveness in protecting people exposed to the coronavirus.
Read More
Novavax results are promising, hope company starts trial on children soon:
Updated : 4 years, 9 months ago IST
New Delhi [India], June 15 (ANI): The Centre on Tuesday said clinical trials of the Novavax COVID-19 vaccine in India are in an advanced stage of completion and hoped the US-based company will soon start trials of its protein-based vaccine on children too.
Read More
The new app brings hope to 70,000 cancer patients seeking reliable informa
Updated : 4 years, 9 months ago IST
Pune (Maharashtra) [India], June 15 (ANI/PNN): Cancer patients in India now have access to CURIA, a first-of-its-kind app developed by Swiss company OncoCoin AG, the most decentralized and equitable ecosystem of cancer information. CURIA, with a global community of over 150,000, empowers pat
Read More
AIIMS Delhi to start screening children aged 6-12 yrs for Covaxin trials f
Updated : 4 years, 9 months ago IST
New Delhi [India], June 14 (ANI): The screening of children aged 6 to 12 years for the clinical trials of indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin is scheduled to start from Tuesday.
Read More
Bharat Biotech to undertake clinical trials in US
Updated : 4 years, 9 months ago IST
New Delhi [India], June 12 (ANI): India's first indigenous COVID-19 vaccine manufacturer Bharat Biotech on Saturday said that it will be carrying out clinical trials in the US to support the marketing application for Covaxin in the country.
Read More
AIIMS Delhi to start screening children for Covaxin trials from Monday
Updated : 4 years, 9 months ago IST
New Delhi [India], June 6 (ANI): The All India Institute of Medical Sciences (AIIMS), Delhi, will start screening children for clinical trials of indigenous home-grown COVID-19 vaccine, Bharat Biotech's Covaxin, from Monday, sources said.
Read More